These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

110 related articles for article (PubMed ID: 36634548)

  • 61. Site of latest activation in patients eligible for cardiac resynchronization therapy: patterns of dyssynchrony among different QRS configurations and impact of heart failure etiology.
    van Bommel RJ; Ypenburg C; Mollema SA; Borleffs CJ; Delgado V; Bertini M; Marsan NA; van der Wall EE; Schalij MJ; Bax JJ
    Am Heart J; 2011 Jun; 161(6):1060-6. PubMed ID: 21641351
    [TBL] [Abstract][Full Text] [Related]  

  • 62. Frequency of inter- and intraventricular dyssynchrony in patients with heart failure according to QRS width.
    Emkanjoo Z; Esmaeilzadeh M; Mohammad Hadi N; Alizadeh A; Tayyebi M; Sadr-Ameli MA
    Europace; 2007 Dec; 9(12):1171-6. PubMed ID: 17951575
    [TBL] [Abstract][Full Text] [Related]  

  • 63. Myocardial Effects of Aldosterone Antagonism in Heart Failure With Preserved Ejection Fraction.
    McDiarmid AK; Swoboda PP; Erhayiem B; Bounford KA; Bijsterveld P; Tyndall K; Fent GJ; Garg P; Dobson LE; Musa TA; Foley JRJ; Witte KK; Kearney MT; Greenwood JP; Plein S
    J Am Heart Assoc; 2020 Jan; 9(1):e011521. PubMed ID: 31852424
    [TBL] [Abstract][Full Text] [Related]  

  • 64. Prognostic importance of pathophysiologic markers in patients with heart failure and preserved ejection fraction.
    Burke MA; Katz DH; Beussink L; Selvaraj S; Gupta DK; Fox J; Chakrabarti S; Sauer AJ; Rich JD; Freed BH; Shah SJ
    Circ Heart Fail; 2014 Mar; 7(2):288-99. PubMed ID: 24365774
    [TBL] [Abstract][Full Text] [Related]  

  • 65. Electroanatomic Ratios and Mortality in Patients With Heart Failure: Insights from the ASIAN-HF Registry.
    Chyou JY; Tay WT; Anand IS; Teng TK; Yap JJL; MacDonald MR; Chopra V; Loh SY; Shimizu W; Abidin IZ; ; Richards AM; Butler J; Lam CSP
    J Am Heart Assoc; 2021 Mar; 10(6):e017932. PubMed ID: 33719492
    [TBL] [Abstract][Full Text] [Related]  

  • 66. Effect of Obesity on Response to Spironolactone in Patients With Heart Failure With Preserved Ejection Fraction.
    Elkholey K; Papadimitriou L; Butler J; Thadani U; Stavrakis S
    Am J Cardiol; 2021 May; 146():36-47. PubMed ID: 33529620
    [TBL] [Abstract][Full Text] [Related]  

  • 67. Subtle QRS changes are associated with reduced ejection fraction, diastolic dysfunction, and heart failure development and therapy responsiveness: Applications for artificial intelligence to ECG.
    García-Escobar A; Vera-Vera S; Jurado-Román A; Jiménez-Valero S; Galeote G; Moreno R
    Ann Noninvasive Electrocardiol; 2022 Nov; 27(6):e12998. PubMed ID: 35904538
    [TBL] [Abstract][Full Text] [Related]  

  • 68. Regional variation in patients and outcomes in the Treatment of Preserved Cardiac Function Heart Failure With an Aldosterone Antagonist (TOPCAT) trial.
    Pfeffer MA; Claggett B; Assmann SF; Boineau R; Anand IS; Clausell N; Desai AS; Diaz R; Fleg JL; Gordeev I; Heitner JF; Lewis EF; O'Meara E; Rouleau JL; Probstfield JL; Shaburishvili T; Shah SJ; Solomon SD; Sweitzer NK; McKinlay SM; Pitt B
    Circulation; 2015 Jan; 131(1):34-42. PubMed ID: 25406305
    [TBL] [Abstract][Full Text] [Related]  

  • 69. Effects of spironolactone in heart failure with preserved ejection fraction: A meta-analysis of randomized controlled trials.
    Li S; Zhang X; Dong M; Gong S; Shang Z; Jia X; Chen W; Yang J; Li J
    Medicine (Baltimore); 2018 Aug; 97(35):e11942. PubMed ID: 30170387
    [TBL] [Abstract][Full Text] [Related]  

  • 70. Relationship between QRS duration and left ventricular mass and volume in patients at high cardiovascular risk.
    Stewart RA; Young AA; Anderson C; Teo KK; Jennings G; Cowan BR
    Heart; 2011 Nov; 97(21):1766-70. PubMed ID: 21835757
    [TBL] [Abstract][Full Text] [Related]  

  • 71. Interaction of Left Ventricular Size and Sex on Outcome of Cardiac Resynchronization Therapy Among Patients With a Narrow QRS Duration in the EchoCRT Trial.
    Varma N; Sogaard P; Bax JJ; Abraham WT; Borer JS; Dickstein K; Singh JP; Gras D; Holzmeister J; Brugada J; Ruschitzka F
    J Am Heart Assoc; 2018 May; 7(11):. PubMed ID: 29807890
    [TBL] [Abstract][Full Text] [Related]  

  • 72. LV mechanical dyssynchrony in heart failure with preserved ejection fraction complicating acute coronary syndrome.
    Lee AP; Zhang Q; Yip G; Fang F; Liang YJ; Xie JM; Lam YY; Yu CM
    JACC Cardiovasc Imaging; 2011 Apr; 4(4):348-57. PubMed ID: 21492809
    [TBL] [Abstract][Full Text] [Related]  

  • 73. Twist/untwist parameters are promising evaluators of myocardial mechanic changes in heart failure patients with preserved ejection fraction.
    Zhang Y; Li SY; Xie JJ; Wu Y
    Clin Cardiol; 2020 Jun; 43(6):587-593. PubMed ID: 32212277
    [TBL] [Abstract][Full Text] [Related]  

  • 74. Mineralocorticoid receptor antagonists in heart failure with preserved ejection fraction (HFpEF).
    Capuano A; Scavone C; Vitale C; Sportiello L; Rossi F; Rosano GM; Coats AJ
    Int J Cardiol; 2015 Dec; 200():15-9. PubMed ID: 26404747
    [TBL] [Abstract][Full Text] [Related]  

  • 75. Poorer Exercise Accommodation of Regional Systolic Myocardial Motion after Spironolactone Treatment in Heart Failure Patients with Preserved Ejection Fraction and Ventricular Dyssynchrony.
    Yu CC; Chiu FC; Tsai CT; Wang YC; Lai LP; Hwang JJ; Lin JL
    J Clin Med; 2021 Aug; 10(17):. PubMed ID: 34501280
    [TBL] [Abstract][Full Text] [Related]  

  • 76. Spironolactone in Patients With Heart Failure, Preserved Ejection Fraction, and Worsening Renal Function.
    Beldhuis IE; Myhre PL; Bristow M; Claggett B; Damman K; Fang JC; Fleg JL; McKinlay S; Lewis EF; O'Meara E; Pitt B; Shah SJ; Vardeny O; Voors AA; Pfeffer MA; Solomon SD; Desai AS
    J Am Coll Cardiol; 2021 Mar; 77(9):1211-1221. PubMed ID: 33663739
    [TBL] [Abstract][Full Text] [Related]  

  • 77. Dyskalemia in people at increased risk for heart failure: findings from the heart 'OMics' in AGEing (HOMAGE) trial.
    Monzo L; Ferreira JP; Cleland JGF; Pellicori P; Mariottoni B; Verdonschot JAJ; Hazebroek MR; Collier TJ; Cuthbert JJ; Pieske B; Edelmann F; Petutschnigg J; Khan J; Ahmed FZ; Girerd N; Bozec E; Díez J; González A; Clark AL; Cosmi F; Staessen JA; Heymans S; Rossignol P; Zannad F
    ESC Heart Fail; 2022 Dec; 9(6):4352-4357. PubMed ID: 36065795
    [TBL] [Abstract][Full Text] [Related]  

  • 78. Prognostic Relevance of Left Atrial Dysfunction in Heart Failure With Preserved Ejection Fraction.
    Santos AB; Roca GQ; Claggett B; Sweitzer NK; Shah SJ; Anand IS; Fang JC; Zile MR; Pitt B; Solomon SD; Shah AM
    Circ Heart Fail; 2016 Apr; 9(4):e002763. PubMed ID: 27056882
    [TBL] [Abstract][Full Text] [Related]  

  • 79. Increased Myocardial Stiffness in Patients With High-Risk Left Ventricular Hypertrophy: The Hallmark of Stage-B Heart Failure With Preserved Ejection Fraction.
    Hieda M; Sarma S; Hearon CM; Dias KA; Martinez J; Samels M; Everding B; Palmer D; Livingston S; Morris M; Howden E; Levine BD
    Circulation; 2020 Jan; 141(2):115-123. PubMed ID: 31865771
    [TBL] [Abstract][Full Text] [Related]  

  • 80. Effect of endurance exercise training on endothelial function and arterial stiffness in older patients with heart failure and preserved ejection fraction: a randomized, controlled, single-blind trial.
    Kitzman DW; Brubaker PH; Herrington DM; Morgan TM; Stewart KP; Hundley WG; Abdelhamed A; Haykowsky MJ
    J Am Coll Cardiol; 2013 Aug; 62(7):584-92. PubMed ID: 23665370
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.